loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 204822 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Novartis Pharmaceuticals Corporation

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 NOVARTIS (1)

    filter

    01 SOLUTION/DROPS;OPHTHALMIC (1)

    filter

    01 DISCN (1)

    filter

    01 IZBA (1)

    filter

    01 Yes (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TRAVOPROST

    PDF Supplier PDF
    URL Supplier Web Content
    SOLUTION/DROPS; OP...
    0.003% **Federal R...
    2014-05-15
    204822
    IZBA
    DISCN
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 204822

    Looking for FDA Orange Book APPLICATION 204822 1

    19

    Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is TRAVOPROST, with a corresponding application number 204822.

    Regulatory Information DISCN

    With a dosage strength 0.003% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Dosage Form Route SOLUTION/DROPS; OPHTHALMIC

    Reference Listed Drug Yes

    Approved since 2014-05-15

    Post Enquiry
    POST ENQUIRY